Refractory Wegener's meningitis treated with rituximab [13]

Journal of Rheumatology

Volumn 34, Issue 4, 2007, Pages 900-902

  Bawa, Sandeep ^a   Mukhtyar, Chetan ^a   Edmonds, Sally ^b   Webley, Michael ^b  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; HEADACHE; HUMAN; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; NERVE PARALYSIS; NEUROLOGIC EXAMINATION; PAPILLEDEMA; PRIORITY JOURNAL; REFRACTORY WEGENER MENINGITIS; RELAPSE; REMISSION; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MENINGITIS, ASEPTIC; WEGENER GRANULOMATOSIS;

EID: 34247355022     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. The Wegener's Granulomatosis Etanercept Trial Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002;23:450-68.
2. Al Dhanhani A, Macaulay R, Maloney B, et al. Meningeal involvement in Wegener's granulomatosis. J Rheumatol 2006;33:364-7.
3. Cheng TM, O'Neill BP, Scheithauer BW, Piepgras DG. Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurgery 1994;34:590-5.
4. Di Comite G, Bozzolo EP, Praderio L, Tresoldi M, Sabbadini MG. Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin Exp Rheumatol 2006;24 Suppl 41:S060-S064.
5. Fam AG, Lavine E, Lee L, Perez-Ordonez B, Goyal M. Cranial pachymeningitis: an unusual manifestation of Wegener's granulomatosis. J Rheumatol 2003;30:2070-4.
6. Spranger M, Schwab S, Meinck HM, et al. Meningeal involvement in Wegener's granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid. Neurology 1997;48:263-5.
7. Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol 2003;30:80-8.
8. The Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. New Engl J Med 2005;352:351-61.
9. Mukhtyar C, Luqmani R. Current state of tumour necrosis factor-α blockade in Wegener's granulomatosis. Ann Rheum Dis 2005;64 Suppl 4:iv31-6.
10. Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:262-8.